Literature DB >> 9188446

A point mutation of human nucleoside diphosphate kinase A found in aggressive neuroblastoma affects protein folding.

I Lascu1, S Schaertl, C Wang, C Sarger, A Giartosio, G Briand, M L Lacombe, M Konrad.   

Abstract

The point mutation serine 120 to glycine in the human nucleoside diphosphate kinase A has been identified in several aggressive neuroblastomas (Chang, C. L., Zhu, X. X., Thoraval, D. H., Ungar, D., Rawwas, J., Hora, N., Strahler, J. R., Hanash, S. M. & Radany, E. (1994) Nature 370, 335-336). We expressed in bacteria and purified wild-type and S120G mutant nucleoside diphosphate kinase A. The mutant enzyme had enzymatic and structural properties similar to the wild-type enzyme, whereas its stability to denaturation by heat and urea was markedly reduced. More importantly, upon renaturation of the urea-denatured mutant protein, a folding intermediate accumulated, having the characteristics of a molten globule. It had no tertiary structure, as shown by near UV circular dichroism, whereas the secondary structure was substantially recovered. The hydrophobic probe 8-anilino-1-naphthalene sulfonate bound to the intermediate species with an increase in fluorescence intensity and a blue shift. The hydrodynamic size was between that expected for a folded and an unfolded monomer. Finally, electrophoresis in a transverse urea gradient displayed no renaturation curve, and the protein showed the tendency to aggregate at the lowest urea concentrations. The existence of a molten globule folding intermediates resulting from an altered folding in the mutated protein might be related to the aggressiveness of neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188446     DOI: 10.1074/jbc.272.25.15599

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Quaternary structure of nucleoside diphosphate kinases.

Authors:  L Lascu; A Giartosio; S Ransac; M Erent
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 2.  NM23/nucleoside diphosphate kinase and signal transduction.

Authors:  A S Otero
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 3.  Protein interactions provide new insight into Nm23/nucleoside diphosphate kinase functions.

Authors:  D Lombardi; A M Mileo
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

4.  Nm23-H1/NDP kinase folding intermediates and cancer: a hypothesis.

Authors:  Ioan Lascu
Journal:  J Bioenerg Biomembr       Date:  2006-09-01       Impact factor: 2.945

5.  Crystal structures of S120G mutant and wild type of human nucleoside diphosphate kinase A in complex with ADP.

Authors:  Marie-France Giraud; Florian Georgescauld; Ioan Lascu; Alain Dautant
Journal:  J Bioenerg Biomembr       Date:  2006-09-01       Impact factor: 2.945

Review 6.  Commentary: nm23, a metastasis suppressor gene with a tumor suppressor gene aptitude?

Authors:  Daniela Lombardi
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

7.  Nm23-H1: genetic alterations and expression patterns in tumor metastasis.

Authors:  M T Hartsough; P S Steeg
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

8.  In vivo cross-linking of nm23/nucleoside diphosphate kinase to the PDGF-A gene promoter.

Authors:  Laura Cervoni; Paola Pietrangeli; Silvia Chichiarelli; Fabio Altieri; Lorenza Egistelli; Carlo Turano; Ioan Lascu; Anna Giartosio
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

9.  Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils.

Authors:  Florian Georgescauld; Raimon Sabaté; Alba Espargaró; Salvador Ventura; Stéphane Chaignepain; Marie-Lise Lacombe; Ioan Lascu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-12       Impact factor: 3.000

10.  nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.

Authors:  Ju-Han Lee; Su Jin Cho; Xianglan Zhang; Zhenlong Zheng; Eung Seok Lee; Aeree Kim; Young-Sik Kim; Yang-Seok Chae; Insun Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.